Intravenous Regional Block with Phentolamine in the Treatment of Complex regional Pain Syndrome
Complex regional pain syndrome (CRPS) is a variety of painful conditions following injury which appears regionally having a distal predominance of abnormal findings. This study, evaluate the use of phentolamine for sympathetic block and regional anesthesia in treatment of CRPS related pain. In this study, 68 patients with CRPS who were referred to pain clinics of Imam Hossein and Akhtar Hospitals and Gandy Center of Surgery between 2003-2008 were evaluated. Forty three of 87 patients finally undertaken intravenous regional sympatholytic block according to therapeutic protocol. 37 patients (86%) received one block, 2 of them (4.75%) received 2 repetitions of blocks and finally repeated block for three times occurred in 4 patients (9.3%). A week after block pain relief outcomes was recorded as following; excellent in 7 patients (16.3%), good in the 32 patients (74.4%) and moderate in the 4 patients (9.3%). After a month, 8 patients (18.5%) showed excellent relief and it was good and moderate in 32 (78%) and one case (2.4%), respectively. Pain relief after three months was excellent, good and moderate in the 13 patients (31.7%), 25 patients (61%) and 3 patients (7.3%), respectively. In this study level of pain relief was significant in various intervals and it showed significant difference in relief three months after block (P=0.04). CRPS due to SMP(sympathetically maintained pain) is thought to be alleviated by phentolamine. Intravenous phentolamine infusion is potentially a new significant option for the therapy of CRPS.
Sharma A, Agarwal S, Broatch J, Raja SN. A web-based cross-sectional epidemiological survey of complex regional pain syndrome. Reg Anesth Pain Med 2009;34(2):110-5.
Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 1993;342(8878):1012-6.
de Mos M, de Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a population-based study. Pain 2007;129(1-2):12-20.
Sandroni P, Benrud-Larson LM, McClelland RL, Low PA. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 2003;103(1-2):199-207.
Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Gilman AG, Limbird LE, editors. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill; 1996. p. 177-97.
Shir Y, Cameron LB, Raja SN, Bourke DL. The safety of intravenous phentolamine administration in patients with neuropathic pain. Anesth Analg 1993;76(5):1008-11.
Raja SN, Treede RD, Davis KD, Campbell JN. Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiology 1991;74(4):691-8.
Abram SE, Haddox JD, editors. The Pain Clinic Manual. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 177-84.
Blanchard J, Ramamurthy S, Walsh N, Hoffman J, Schoenfeld L. Intravenous regional sympatholysis: a double-blind comparison of guanethidine, reserpine, and normal saline. J Pain Symptom Manage 1990;5(6):357-61.
Hord AH, Rooks MD, Stephens BO, Rogers HG, Fleming LL. Intravenous regional bretylium and lidocaine for treatment of reflex sympathetic dystrophy: a randomized, double-blind study. Anesth Analg 1992;74(6):818-21.
Galer BS. Peak pain relief is delayed and duration of relief is extended following intravenous phentolamine infusion. Preliminary report. Reg Anesth 1995;20(5):444-7.
Lee DH, Liu X, Kim HT, Chung K, Chung JM. Receptor subtype mediating the adrenergic sensitivity of pain behavior and ectopic discharges in neuropathic Lewis rats. J Neurophysiol 1999;81(5):2226-33.
Ren Y, Zou X, Fang L, Lin Q. Sympathetic modulation of activity in Adelta- and C-primary nociceptive afferents after intradermal injection of capsaicin in rats. J Neurophysiol 2005;93(1):365-77.
Sato J, Suzuki S, Iseki T, Kumazawa T. Adrenergic excitation of cutaneous nociceptors in chronically inflamed rats. Neurosci Lett 1993;164(1-2):225-8.
Shannon HE, Lutz EA. Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin(1A) receptors. Psychopharmacology (Berl). 2000 Mar;149(1):93-7.
Chen Y, Michaelis M, Janig W, Devor M. Adrenoreceptor subtype mediating sympathetic-sensory coupling in injured sensory neurons. J Neurophysiol 1996;76(6):3721-30.
Kingery WS, Guo TZ, Davies MF, Limbird L, Maze M. The alpha(2A) adrenoceptor and the sympathetic postganglionic neuron contribute to the development of neuropathic heat hyperalgesia in mice. Pain 2000;85(3):345-58.
Leem JW, Gwak YS, Nam TS, Paik KS. Involvement of alpha2-adrenoceptors in mediating sympathetic excitation of injured dorsal root ganglion neurons in rats with spinal nerve ligation. Neurosci Lett 1997;234(1):39-42.
Sato J, Perl ER. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 1991;251(5001):1608-10.
Tracey DJ, Cunningham JE, Romm MA. Peripheral hyperalgesia in experimental neuropathy: mediation by alpha 2-adrenoreceptors on post-ganglionic sympathetic terminals. Pain 1995;60(3):317-27.
Vucković SM, Tomić MA, Stepanović-Petrović RM, Ugresić N, Prostran MS, Bosković B. The effects of alpha2-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain. Pain 2006;125(1-2):10-9.
Xie Y, Zhang J, Petersen M, LaMotte RH. Functional changes in dorsal root ganglion cells after chronic nerve constriction in the rat. J Neurophysiol 1995;73(5):1811-20.
Verdugo RJ, Ochoa JL. Sympathetically maintained pain. I. Phentolamine block questions the concept. Neurology 1994;44(6):1003-10.
Galer BG, Schwartz L, Allen RJ. Complex regional pain syndromes: Type I: reflex sympathetic dystrophy, and Type II: causalgia. In: Loeser JD, editor. Bonica's Management of Pain. 3rd ed. Philadelphia: Lippincott, Williams and Wilkins; 2001. p. 405.
Presley RW. Novel approaches to the treatment of neuropathic pain. West J Med 1992;157(5):564.